Increasing access to and availability of sustainable, high quality, comprehensive and evidence-based behavioral, biomedical and structural HIV prevention services among key populations and priority populations in Nairobi, Central and Eastern regions | CDC RFA GH16 171702CONT18

Opportunity Information: Apply for CDC RFA GH16 171702CONT18

This funding opportunity is a continuation cooperative agreement issued by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), under the Center for Global Health (CGH). It sits within the public health and HIV portfolio funded through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and is focused specifically on Kenya. The overarching purpose is to expand access to, and availability of, sustainable and high quality HIV prevention services that are comprehensive, evidence-based, and designed to meet the realities of populations at elevated risk of HIV acquisition.

The program’s geographic focus is Kenya’s Nairobi, Central, and Eastern regions, with an emphasis on reaching key populations and other priority populations. While the notice text provided does not enumerate the groups, in PEPFAR and CDC prevention programming, "key populations" typically refers to communities that experience disproportionate HIV risk and barriers to care (often due to stigma, criminalization, discrimination, mobility, or social and economic vulnerabilities). "Priority populations" generally refers to groups identified in national or regional epidemic data as important for prevention impact, including people with heightened exposure risk, those underserved by routine health services, and groups central to reducing onward transmission in high-incidence settings. The intent is to support targeted, data-driven approaches that expand coverage where prevention impact is likely to be highest.

The services described are intentionally broad and multi-layered, covering behavioral, biomedical, and structural interventions. Behavioral prevention generally means risk-reduction counseling and education, peer and community outreach, behavior change communication, condom promotion and distribution, and activities that support uptake and adherence to prevention methods. Biomedical prevention typically includes interventions delivered through the health system such as HIV testing services and linkage, sexually transmitted infection (STI) screening and treatment, post-exposure prophylaxis (PEP) where indicated, voluntary medical male circumcision (where relevant), and other clinical prevention tools that reduce acquisition risk. Structural interventions are meant to address the social and systemic barriers that keep people from using services, such as stigma and discrimination, violence risk, legal and policy obstacles, transportation and access challenges, and weaknesses in service delivery systems. The program language signals that CDC expects a combination prevention model rather than isolated activities, with each component reinforcing the others.

Because this is a cooperative agreement, it implies substantial involvement by CDC in program implementation and oversight rather than a hands-off grant structure. In practice, cooperative agreements usually include close technical collaboration, shared planning, and ongoing performance monitoring. The focus on sustainability and quality indicates expectations beyond short-term service delivery, including strengthening systems, building local capacity, institutionalizing evidence-based practices, and improving the consistency and standards of prevention services over time. The emphasis on "comprehensive" and "evidence-based" also implies alignment with proven interventions, use of guidelines and standards, and continuous quality improvement approaches.

Administratively, the opportunity is identified as "CDC RFA GH16 171702CONT18" and is categorized as a continuation opportunity rather than a brand-new open competition. The funding instrument type is a cooperative agreement, and the funding activity category is health, with CFDA number 93.067. The eligible applicant category is listed as "Others," with further clarification referenced in an additional eligibility field not included in the provided excerpt, meaning eligibility may be limited to specific organizations (for example, existing recipients, named partners, or organizations meeting particular criteria) depending on the full notice.

Key dates and scale indicators from the listing include a creation date of January 30, 2017 and an original closing date of March 31, 2017. The listing notes an expectation of 10 awards. The award ceiling is shown as 0, which commonly indicates that either the ceiling is not specified in the summarized record, the award amounts are determined through other documentation, or the ceiling is not captured in that field for this posting. Overall, the opportunity is designed to support multiple implementing partners to expand and sustain high-impact HIV prevention programming for populations most affected by risk and access barriers in the specified Kenyan regions under the broader PEPFAR strategy.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Increasing access to and availability of sustainable, high quality, comprehensive and evidence-based behavioral, biomedical and structural HIV prevention services among key populations and priority populations in Nairobi, Central and Eastern regions" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Jan 30, 2017.
• Applicants must submit their applications by Mar 31, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH16 171702CONT18

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: